|
Press Releases |
|
|
|
Saturday, June 30, 2012 |
|
Vivus Shares Set to Gain from Qnexa Despite Vulnerability |
Vivus (NASDAQ:VVUS) is a company focused on obesity drugs. Its lead candidate, Qnexa, aims to curb obesity in patients with an extended release capsule containing 2 FDA-approved compounds (phentermine and topiramate). more info >> |
|
Thursday, June 28, 2012 |
|
Psivida: Small-Cap Ophthalmology-Based BioTech Positioned for Long-Term Growth |
pSivida (NASDAQ:PSDV)develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection or insertion. more info >> |
|
Wednesday, June 27, 2012 |
|
Armed with Impressive Partnerships, Can This Emerging Innovator Become 2012's Most Successful Medical Device IPO? |
Image-guided surgery has revolutionized the accuracy and cost of performing surgery - creating minimally-invasive procedures that allow patients quicker recovery and save clinics, physicians, patients, and health insurers time and money. more info >> |
|
Friday, June 22, 2012 |
|
CEO Sees FDA's Designation as Significant Validation of Medgenics' Novel Technology for Treatment of hepatitis D |
In near record time, Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of Medgenics has helped position his relatively new publicly traded company at a much higher level-- one that most other biotech firms usually take far longer to reach. more info >> |
|
Wednesday, June 20, 2012 |
|
Can QRx Pharma Land A Positive FDA Decision? |
Sydney, Australia based QRx Pharma (PINK:QRXPY) (PINK:QRXPF) (ASX:QRX) is a pharmaceutical company with the vast majority of its prospects tied up in a single drug - MoxDuo. MoxDuo is a combination of two widely used opioids (3:2 ratio of morphine and oxycodone). more info >> |
|
Lpath Shares Breaking Out As Investors Seize Discounted Shares |
Shares of LPath, Inc (NASDAQ:LPTN) are up over 10% in early trading on Tuesday following a report detailing why shares at current prices were a good bet for biotech investors. more info >> |
|
Friday, June 15, 2012 |
|
Orgenesis' Sarah Ferber, Ph.D on Using a Diabetes Patient's Own Liver Cells as a Novel Source of Insulin |
Diabetes currently afflicts approximately 285 million people worldwide, about 6.4 percent of the global population. The World Health Organization projects that this number is set to rise to 366 million by the year 2030. more info >> |
|
Friday, March 23, 2012 |
|
Healthcare Investors and Capitalists Actively Looking for the Next Generation of Market Movers |
They may be some of the most talked about market movers today, but companies like Alimera Sciences (Nasdaq:ALIM), Pozen (Nasdaq:POZN), Threshold Pharmaceuticals (Nasadq: THLD), Arena Pharmaceuticals (Nasdaq:ARNA) and others were once only ideas looking for early investors to back and believe in them. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market
May 17, 2024 18:00 HKT/SGT
|
|
|
CITIC Telecom CPC's Innovation Excellence Honored with 2 Innovation Awards
May 17, 2024 17:37: JST
|
|
|
中信国际电讯CPC守正创新 AI创新方案喜迎两大奖
May 17, 2024 17:04 HKT/SGT
|
|
|
中信國際電訊CPC守正創新 AI創新方案喜迎兩大獎
May 17, 2024 16:55 HKT/SGT
|
|
|
CITIC Telecom CPC's Innovation Excellence Honored with 2 Innovation Awards
May 17, 2024 16:37 HKT/SGT
|
|
|
London Climate Technology Show 2024 Returns For Third Edition at ExCeL London
May 17, 2024 15:48: JST
|
|
|
London Climate Technology Show 2024 Returns For Third Edition at ExCeL London
May 17, 2024 15:48 HKT/SGT
|
|
|
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers
May 17, 2024 15:00 HKT/SGT
|
|
|
Sri Trang (SET: STA) announces delivery of EUDR rubber to customers
May 17, 2024 15:00 HKT/SGT
|
|
|
富士通、論理推論を可能とする大規模言語モデルの研究開発が「GENIAC」に採択
May 17, 2024 14:00: JST
|
|
|
Fujitsu chosen for GENIAC project, starts development of large language models for logical reasoning
May 17, 2024 14:03 JST
|
|
|
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud
May 17, 2024 11:19 JST
|
|
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
May 16, 2024 22:00 HKT/SGT
|
|
|
加速大灣區互聯互通,內地乘客可在曹操出行下單大巴直達港澳
May 16, 2024 21:52 HKT/SGT
|
|
|
DEXIS Innovation Continues With New DEXIS Ti2 Sensor as Successor to the DEXIS Titanium Sensor, the #1 Selling Intraoral Sensor in the United States
May 16, 2024 21:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|